Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (2): 241-244    DOI: 10.12891/ceog4404.2019
Original Research Previous articles | Next articles
Effect of the FSH receptor polymorphism on the age at menarche
O.S. Kerimoglu1, *(), A. Pekin1, S.A. Yılmaz1, F.N. İncesu3, S. Nergiz2, N.U. Doğan4, H. Acar5, C. Celik1
1Obstetrics and Gynecology Department, Selçuk University Medicine Faculty, Konya, Turkey;
2Genetics Department, Selçuk University Medicine Faculty, Konya, Turkey;
3Obstetrics and Gynecology Department, Konya Research and Training Hospital, Konya, Turkey
4Obstetrics and Gynecology Department, Akdeniz University Medicine Faculty, Antalya, Turkey
5Genetics Department, Selçuk University, Konya, Turkey;
Download:  PDF(197KB)  ( 38 ) Full text   ( 3 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Summary: Estrogen and estrogen receptor (ER) genes have an effect on the age at menarche. Follicle stimulating hormone (FSH) is an important hormone that plays a major role in the regulation of folliculogenesis and estrogen synthesis. The aim of this study was to investigate the influence of the FSH receptor (FSHR) polymorphisms Asn680Ser and Thr307Ala on age at menarche. Materials and Methods: FSH receptor gene polymorphisms were investigated in women who were admitted to Selcuk University between May 2013 and November 2014. Information about age at menarche was obtained through interviews. Polymorphic analysis of the FSH receptor gene was performed in 209 healthy female patients who had undergone an annual health examination. Genomic DNA was obtained from peripheral blood leukocytes, and polymorphisms were investigated using restriction fragment length polymorphism analysis. Results: The mean age at menarche was 12.95 ± 1.62 years. The overall frequencies for Asn680Ser variants NN, NS, and SS were 40.2%, 36.4%, and 23.4%, respectively, whereas Thr307Ala variants TT, TA, and AA were 34.4%, 41.1%, and 24.4%, respectively. Menarche occurred 3.6 months earlier in subjects with TN homozygote genotype than in AS homozygotes, and the mean age at menarche was 2.5 months earlier in TN homozygotes compared with that in all other study subjects, but the differences were not statistically significant (p = 0.966 and p = 0.986, respectively). Conclusions: The Ala307Thr and Ser680Asn polymorphisms of the FSHR gene are not associated with age at menarche.

Key words:  Menarche age      FSH receptor      Polymorphism      Estrogen receptor     
Published:  10 April 2019     
*Corresponding Author(s):  O.S. KERIMOGLU     E-mail:  ozlemsecilmis@hotmail.com

Cite this article: 

O.S. Kerimoglu, A. Pekin, S.A. Yılmaz, F.N. İncesu, S. Nergiz, N.U. Doğan, H. Acar, C. Celik. Effect of the FSH receptor polymorphism on the age at menarche. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 241-244.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4404.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I2/241

[1] J. Wang, S.W. Chen, X.Y. Qin, X.Z. Zheng, P. Wang, X.Y. Cai. Clinical application of short tandem repeat polymorphism analysis in the differential diagnosis of early hydatidiform mole and hydropic abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 490-495.
[2] N. Haya, I. Feferkorn, F. Fares, N. Azzam, R. Auslender, Y. Abramov. Elastin genetic point mutation and the risk of pelvic organ prolapse[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 75-78.
[3] H.-H. Lee, M.-J. Mun, T.-H. Kim, Y.-S. Kim, W.-C. Jang, J.-Y. Hwang. Relationships between vitamin D receptor genetic polymorphisms and endometriosis in Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 876-880.
[4] A.M. Malutan, R. Ciortea, C. Porumb, R.F. Mocan-Hognogi, D. Mihu. Vascular endothelial growth factor genetic polymorphisms at +405C/G and -460 C/T and the association with advanced stages of endometriosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 725-730.
[5] A. Jafari, S. Parchami, S. Reiisi, S. Miraj. Association of plasma homocysteine, folic acid levels, and C677T polymorphism in methylene tetra hydrofolate reductase with risk of preeclampsia: a case-control study in Iranian women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 367-374.
[6] H. Ueda, G. Minase, T. Miyamoto, M. Iijima, Y. Saijo, M. Nakashima, N. Matsumoto, M. Namiki, K. Sengoku. Single-nucleotide polymorphisms in ETV5: a risk factor for Sertoli cell-only syndrome in Japanese men?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 187-189.
[7] Y. Yang, B.R. Luo, M. Hu, D.M. Zhao, W.J. Jing. Association of CD36 gene single nucleotide polymorphism with gestational diabetes mellitus in Chinese Han population[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 266-271.
[8] Guiling Wang, Aifang Jiang, Chun'e Ren. The relationship between qh+ and recurrent spontaneous abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 102-104.
[9] Peng Zhang, Qi-wen Wu, Gang Feng, Chun-sheng Liu, Ying-ying Zhang, Chun Pu. Protein Z and anti-protein Z IgG levels, but not the promotor A13G polymorphism, are associated with preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 929-933.
[10] J. H. Check, R. Cohen. A second successful pregnancy using oocytes from a woman with premature ovarian failure with embryos transferred to a gestational carrier[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 507-508.
No Suggested Reading articles found!